Hester Biosciences achieves 94% sales target in India during April-December 2018

29 Jan 2019 Evaluate

Hester Biosciences has achieved 94% sales target in India for the 9 months ended December 31, 2018 (April-December 2018). The profitability improved during the period. This improvement is attributed to a better product mix, better inventory management and a reduction in the cost of production.

Hester Biosciences is engaged in the manufacturing of poultry vaccines.

Hester Biosciences Share Price

1482.80 45.90 (3.19%)
30-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1595.00
Dr. Reddys Lab 1218.40
Cipla 1323.95
Zydus Lifesciences 885.20
Lupin 2151.05
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×